EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Tuning Lipid Nanoparticles for RNA Delivery to Extrahepatic Organs

Donghui Song iD, Yu Zhao, Zeyu Wang, Qiaobing Xu iD

Advanced Materials · 2024-11 · 36 (44)

DOI: 10.1002/adma.202401445 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advanced Materials, online erschienen am 05.09.2024. Verfasst von Donghui Song und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Tufts University, Medford, MA, 02155, USA. Hauptthemen laut MEDLINE: Nanoparticles, Lipids, RNA. Die Arbeit wurde bisher 87-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHGRI NIH HHS, NCATS NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

RNA therapeutics have been successfully transitioned into clinical applications. Lipid nanoparticles (LNPs) are widely employed as nonviral delivery vehicles for RNA therapeutics in commercial vaccine and gene therapy products. However, the bottleneck in expanding the clinical applications of LNP‐based RNA therapeutics lies in the tendency of these nanoparticles to preferentially accumulate in the liver. This challenge underscores the need to design LNPs capable of delivering RNA to organs beyond the liver. In this perspective, recent progress is discussed in developing strategies for designing LNPs to deliver RNA to extrahepatic organs. Organ‐selective targeting capability is achieved by either altering the composition of the LNP formulation or chemically modifying the ionizable lipid component. Both approaches result in changes in the physicochemical properties of the LNPs, which subsequently alters the composition of the biomolecular corona that adsorbs onto its surface following administration. The biomolecular corona is a known mechanism that mediates organ‐selective LNP delivery. Furthermore, this perspective aims to provide an outlook on shaping the next‐generation LNP delivery platforms. Potential efforts include targeting specific cell types, improving the safety profile of LNPs, and developing strategies to overcome physiological barriers against organ‐specific delivery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanoparticlesLipidsRNAHumansAnimalsLiverGene Transfer TechniquesLiposomes

Stichwörter der Autor:innen

RNA therapeuticsbiomolecular coronalipid nanoparticlesorgan‐selective delivery

Substanzen

LipidsRNALipid NanoparticlesLiposomes

Autor:innen und Institutionen

  • Department of Biomedical Engineering, Tufts University, Medford, MA, 02155, USA.

ORCID-Profile: Donghui Song, Qiaobing Xu

Förderung

  • NHGRI NIH HHS
  • NCATS NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Song, D., Zhao, Y., Wang, Z., & Xu, Q. (2024). Tuning Lipid Nanoparticles for RNA Delivery to Extrahepatic Organs. Advanced Materials, 36(44). https://doi.org/10.1002/adma.202401445

Vancouver

Song D, Zhao Y, Wang Z, Xu Q. Tuning Lipid Nanoparticles for RNA Delivery to Extrahepatic Organs. Advanced Materials. 2024;36(44). doi:10.1002/adma.202401445

BibTeX
@article{Song2024,
  author = {Song, Donghui and Zhao, Yu and Wang, Zeyu and Xu, Qiaobing},
  title = {Tuning Lipid Nanoparticles for RNA Delivery to Extrahepatic Organs},
  journal = {Advanced Materials},
  year = {2024},
  volume = {36},
  number = {44},
  doi = {10.1002/adma.202401445}
}
Kostenlos starten →